36-37 / 54
Diretriz
Diretriz
36
37
56.
Lader M. Anxiety or depression during withdrawal of hypnotic
treatments. J Psychosom Res 1994;38 Suppl 1:113-23.
57.
O’Connor K, Marchand A, Brousseau L, Aardema F, Mainguy
N, Landry P, et al. Cognitive-behavioural, pharmacological
and psychosocial predictors of outcome during tapered
discontinuation of benzodiazepine. Clin Psychol Psychother
2008;15:1-14.
58.
Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines
in primary care. CNS Drugs 2009;23:19-34.
59.
Chaimowicz F, Ferreira T de J, Miguel DF. Use of psychoactive
drugs andrelated falls amongolderpeople living ina community
in Brazil. Rev Saude Publica 2000; 34:631-5.
60.
Haasum Y, Fastbom J, Johnell K. Institutionalization as a risk
factor for inappropriate drug use in the elderly: a Swedish
nationwide register-based study. Ann Pharmacother.
2012;46:339-46.
61.
Barbone F, Mcmahon AD, Davey PG, Morris AD, Reid IC,
Mcdevitt DG, et al. Association of road-traffic accidents with
benzodiazepine use. Lancet 1998;352:1324-5.
62.
RomãoMR,VieiraLJES. Tentativas suicidaspor envenenamento.
Rev Bras Prom Saude 2004;17:14-20.
63.
Dell’osso B, Lader M. Do benzodiazepines still deserve a
major role in the treatment of psychiatric disorders? A critical
reappraisal. Eur Psychiatry 2013;28:7-20.
64.
Auchewskia L, Andreatini, R, Galduróz J C, Lacerda RB
Avaliação da orientação médica sobre os efeitos colaterais de
benzodiazepínicos. Escola Paulista de Medicina. São Paulo,
SP, Brasil. Centro Brasileiro de Informações sobre Drogas
Psicotrópicas (CEBRID). 2004 São Paulo, SP, Brasil
65.
Stewart SA. The effects of benzodiazepines on cognition. J Clin
Psychiatry 2005;66 Suppl 2:9-13
66. Peres RM, Segal J, Carvalho CA, Moser C, Sanseverino MTV,
Schuler-Faccini L. Riscos para a saúde fetal associados com
o uso de benzodiazepínicos na gestaçäo: uma revisäo J Bras
Psiquiatr 2002;51:145-51.
67.
Dolovich LR, Addis A, Vaillancourt JMR, Power JD, Koren
G, Einarson T. Benzodiazepine use in pregnancy and major
malformations or oral cleft: meta-analysis of cohort and case-
control studies BMJ 1998;317:839-43.
68.
Laegreid L, Olegård R, Conradi N, Hagberg G, Wahlström
J, Abrahamsson L. Congenital malformations and maternal
consumption of benzodiazepines: a case-control study. Dev
Med Child Neurol 1990; 32:432-41.
69.
McElhatton PR. The effects of benzodiazepine use during
pregnancy and lactation
.
Reprod Toxicol 1994;8:461-75.
70.
Parr JM, Kavanagh DJ, Cahill L, Mitchell G, McD Young
R. Effectiveness of current treatment approaches for
benzodiazepine discontinuation: a meta-analysis. Addiction
2009;104:13-24.
71.
Denis C, Fatseas M, Lavie E, Auriacombe M. Pharmacological
interventions
for
benzodiazepine
mono-dependence
management in outpatient settings. Cochrane Database Syst
Rev 2006;(3):CD005336.
72.
Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines
in primary care. CNS Drugs 2009;23:19-34.
73.
Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M,
Maciocco E, Biggio G. Comparison of the effects of zaleplon,
zolpidem, and triazolam at various GABA
(A)
receptor subtypes.
Eur J Pharmacol 2002;45:103-10.
74.
Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P. Genetics of
dopamine receptors and drug addiction: a comprehensive
review. Behav Pharmacol 2009;20:1-17
75.
Sigel E, Lüscher BP. A closer look at the high affinity
benzodiazepine binding site on GABAA receptors. Curr Top
Med Chem 2011;11:241-6.
76.
VilkmanH, Kajander J, AaltoS, VahlbergT,NågrenK, AllonenT,
et al. The effects of lorazepam on extrastriatal dopamine D(2/3)-
receptors-A double-blind randomized placebo-controlled PET
study. Psychiatry Res 2009;174:130-7.
77.
Scharf MB, Roth T, Vogel GW, Walsh JK. A multicenter,
placebo-controlled studyevaluating zolpidem in the treatment
of chronic insomnia. J Clin Psychiatry 1994;55:192-9.
78.
Rush CR. Behavioral pharmacology of zolpidem relative
to benzodiazepines: a review. Pharmacol Biochem Behav
1998;61:253-69.
79.
Vicens C, Socias I, Mateu C, Leiva A, Bejarano F, Sempere E,
et al. Comparative efficacy of two primary care interventions
to assist withdrawal from long term benzodiazepine use: a